Table 1.
Clinicopathological characteristics of the tumors (n = 52)
| Characteristics | No. | % |
|---|---|---|
| Clinical T categories | ||
| T1c | 5 | 9.6 |
| T2 | 39 | 75 |
| T3 | 5 | 9.6 |
| T4 | 3 | 5.8 |
| Clinical N categories | ||
| N0 | 21 | 40.4 |
| N1 | 19 | 36.5 |
| N2 | 5 | 9.6 |
| N3 | 7 | 13.5 |
| Histology | ||
| Invasive breast carcinomas of no special type (IBC NST) | 48 | 92.3 |
| Other | 4 | 7.7 |
| Grade | ||
| 1 | 0 | 0 |
| 2 | 20 | 38.5 |
| 3 | 32 | 61.5 |
| Biological subtype | ||
| Luminal A | 7 | 13.5 |
| Luminal B/proliferative | 12 | 23.1 |
| Luminal B/Her2-positive | 15 | 28.8 |
| Her2-positive | 6 | 11.5 |
| Triple negative | 12 | 23.1 |
| Primary systemic therapy | ||
| Taxane-anthracycline combination | 19 | 36.5 |
| Taxane-platinum combination | 15 | 28.8 |
| Trastuzumab-based combination | 11 | 21.2 |
| Other | 7 | 13.5 |
| Surgical therapy | ||
| Mastectomy | 35 | 67.3 |
| Breast conserving surgery | 17 | 32.7 |
| Axillary block dissection | 43 | 82.7 |
| Sentinel lymph node biopsy | 9 | 17.3 |